Amphetamine effects on synapses in the brain's reward center

Synaptic Actions of Amphetamine in the Striatum

NIH-funded research New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC · NIH-11294280

This work looks at how amphetamine changes fast signaling between brain cells in reward areas and how that may relate to stimulant addiction in people.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11294280 on NIH RePORTER

What this research studies

Researchers are examining how amphetamine alters communication between nerve cells in the striatum, a brain area important for reward and habit. They focus on rapid synaptic signals carried by dopamine, GABA, and glutamate and on special interneurons that shape circuit activity. The team studies how amphetamine disrupts glutamate co-transmission and causes lasting changes (plasticity) at specific synapses that could push the circuit toward addictive behavior. Findings come from laboratory experiments designed to reveal mechanisms that could guide future treatments for stimulant dependence.

Who could benefit from this research

Good fit: People with a history of amphetamine or other stimulant use disorder, or those at risk of stimulant dependence, would be the most relevant group for future studies informed by this work.

Not a fit: People whose conditions do not involve stimulant-related brain circuits (for example primary opioid or alcohol disorders without stimulant exposure) may not directly benefit from these specific findings.

Why it matters

Potential benefit: If successful, this work could reveal specific synaptic targets that new medications or interventions might use to reduce stimulant craving or relapse.

How similar studies have performed: Prior animal and cellular studies have shown dopamine and glutamate signaling are important for stimulant effects, but translating synaptic findings into human treatments is still early and remains largely unproven.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.